摘要
血小板膜糖蛋白在血小板黏附、聚集和释放反应中起关键作用,是血小板活化的特异性分子标志物。研究证实血小板膜糖蛋白CD62P可较为灵敏且特异地反映冠状动脉的发生发展过程,CD62P的含量与病情程度呈正相关。多种中药能降低CD62P含量,抑制血小板活化,对冠心病的治疗起着重要的作用。
The platelet membrance glycoprotein plays a key role in the adhesion, aggregation and release of platelet. It is the specific molecular marker for platelet activation. Many studies have confirmed that platelet membrane glycoprotein CD62P may be more sensitive and specific to reflect the occurrence of coronary artery development, CD62P level is positively correlated with the severity. A variety of traditional Chinese medicine can lower the CD62P level, inhibit platelet activation and the treatment play an important role in the treatment.
出处
《中国实用内科杂志》
CAS
CSCD
北大核心
2010年第5期465-466,共2页
Chinese Journal of Practical Internal Medicine
关键词
血小板活化
血小板膜糖蛋白
冠心病
中药
CD62P
platelet activation
platelet membrance glyeoprotein
eoronry heart disease
traditional Chinese Medicine
CD62P